◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...
Customize Items
Delta-Fly Pharma,Inc. — Financial Statements
5 10 All
Income Statement
Balance Sheet
Cash Flow
Line ItemQ4 2025Nov 14, 2025Q4 2024Nov 14, 2024Q1 2024Mar 31, 2024Q1 2023Mar 31, 2023Q1 2022Mar 31, 2022
+Operating Income -916.3M -593.5M -- -- --
Operating Margin % 100.0% 99.1% -- -- --
+Ordinary Income -915.9M -599.0M -- -- --
Revenue Growth % -52.9% -- -- -- --
Line ItemQ4 2025Nov 14, 2025Q4 2024Nov 14, 2024Q1 2024Mar 31, 2024Q1 2023Mar 31, 2023Q1 2022Mar 31, 2022
Current Assets 394.7M 1.4B -- -- --
Total Assets 434.3M 1.5B 1.8B 733.6M 1.7B
Current Liabilities 156.5M 241.5M -- -- --
Total Liabilities 156.5M 241.5M 91.0M 123.0M 98.1M
Total Equity 277.8M 1.2B 1.7B 610.5M 1.6B
Equity Ratio -- -- 0.95 0.83 0.94
No data available for this statement.
NEWS
Loading article...
NEWS
Loading news...
TRENDING
Loading...